Lifestance Health Group Stock Alpha and Beta Analysis
| LFST Stock | USD 6.58 0.13 2.02% |
The market risk premium analysis for Lifestance Health Group computes annualized alpha and rolling beta estimates, giving investors a current and historical view of Lifestance Health's risk-adjusted performance relative to the benchmark. Key technical indicators for Lifestance Health's market risk premium analysis include: the following indicators:
Beta 1.28 | Alpha 0.0244 | Risk 2.12 | Sharpe Ratio -0.03 | Expected Return -0.07 |
Enterprise Value | 2.32 Billion |
Investors seeking alpha often accept higher beta as a byproduct of concentrated bets on specific companies or sectors. The risk-adjusted lens of alpha helps determine whether the higher beta exposure was worthwhile.
Lifestance | Build portfolio with Lifestance Stock |
Market Premiums
Market premium analysis for Lifestance Health Group frames the extra return investors may expect for taking on broad market risk. The stronger read comes from combining market premium with volatility, diversification, and the investor's actual time horizon.| α | 0.02 | β | 1.28 |
Expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Lifestance Health's Buy-and-hold return. Our buy-and-hold chart shows how Lifestance Health performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Market Price Analysis
Technical market-price analysis for Lifestance Health Group gives investors another way to read timing, sentiment, and position risk while the broader narrative keeps evolving. For active traders, the edge usually comes from recognizing where Lifestance Health may be setting up for a cleaner entry, a weaker follow-through, or a higher-risk exit.
| Price Series Summation | ||
| Price Series Division | ||
| Inverse Tangent Over Price Movement | ||
| Price Ceiling Movement | ||
| Aroon Oscillator | ||
| Balance Of Power | ||
| Bollinger Bands | ||
| Bollinger Bands | ||
| Belt hold | ||
| Hanging Man |
Return and Market Media
The median price of Lifestance Health for the period between Thu, Dec 18, 2025 and Wed, Mar 18, 2026 is 7.07 with a coefficient of variation of 3.57. The daily time series for the period is distributed with a sample standard deviation of 0.25, arithmetic mean of 7.04, and mean deviation of 0.19. The Stock received a lot of media exposure during the period. Price Growth (%) |
| Timeline |
1 | Disposition of 3221 shares by Bessler Robert of Lifestance Health at 7.0 subject to Rule 16 b-3 | 12/18/2025 |
2 | Disposition of 2450 shares by Bessler Robert of Lifestance Health at 7.01 subject to Rule 16 b-3 | 12/26/2025 |
3 | Life Stance Health Group, Inc. Given Average Rating of Moderate Buy by Brokerages - Market Beat | 01/02/2026 |
4 | Acquisition by Palmer Eric P of 71428 shares of Lifestance Health subject to Rule 16 b-3 | 02/03/2026 |
5 | Principal Financial Group Inc. Has 16.87 Million Holdings in Life Stance Health Group, Inc. LFST | 02/10/2026 |
6 | Disposition of 6185 shares by Bessler Robert of Lifestance Health at 7.0 subject to Rule 16 b-3 | 02/20/2026 |
7 | Life Stance Health Group Q 4 Earnings Call Highlights | 02/25/2026 |
8 | Life Stance Health Group Issues Quarterly Earnings Results | 02/26/2026 |
9 | What Life Stance Health Group s Profit Return, Buyback Plan, and Stock Offerings Mean For Shareholders | 03/02/2026 |
10 | Acquisition by Ryan Mc Groarty of 179856 shares of Lifestance Health subject to Rule 16 b-3 | 03/05/2026 |
11 | Disposition of 21566 shares by Ann Varanakis of Lifestance Health at 6.93 subject to Rule 16 b-3 | 03/06/2026 |
12 | Disposition of 18541 shares by Vukasin Paunovich of Lifestance Health at 6.91 subject to Rule 16 b-3 | 03/09/2026 |
13 | Disposition of 8707 shares by Ann Varanakis of Lifestance Health at 6.91 subject to Rule 16 b-3 | 03/11/2026 |
Performance Metrics & Calculation Methodology
Lifestance Health performance is measured on a risk-adjusted basis against benchmarks. Liquidity conditions can influence realized performance through spreads and execution cost. Lifestance Health shows ROE of 0.65%, ROA of 0.73%.
The analytics block for Lifestance Health Group relies on periodic company reporting and market reference feeds, with quality checks and normalization applied before rendering. Timing can vary by data vendor. Return and risk statistics are calculated from historical price series.
This content is curated and reviewed by:
Rifka Kats - Member of Macroaxis Editorial BoardLifestance Health Upcoming Company Events
Investors following Lifestance Health Group should monitor filing events closely because reporting quality and disclosure discipline can materially affect the investment case. The stronger process is to read disclosures directly and test them against forensic or accounting-based risk measures.
| 13th of March 2024 Upcoming Quarterly Report | View | |
| 8th of May 2024 Next Financial Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View | |
| 13th of March 2024 Next Fiscal Year End | View | |
| 30th of September 2023 Last Quarter Report | View | |
| 31st of December 2022 Last Financial Announcement | View |
Build Portfolio with Lifestance Health
Serious investors usually evaluate Lifestance Health Group in portfolio context because a good security can still be a weak addition if it increases concentration or unnecessary volatility. The practical goal is to remove redundancy, improve diversification, and keep risk aligned with the intended return target.
Build Diversified Portfolios
Align your risk with return expectations
Additional Tools for Lifestance Stock Analysis
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |